Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0000950170-25-009815

Options or other derivatives

  • Principal Accounting Officer acquired 76,120 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Tourangeau Greg · Principal Accounting Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-01-24 Grant or award : show line 1 in the form Stock Option (right to buy) +76,120 76,120 D
Loading xslF345X05/ownership.xml…